Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes-Reference-Cited by-同舟云学术

Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes

Published:2024-01-31 Issue:3 Volume:18 Page:733-740
ISSN:1932-2968
Container-title:Journal of Diabetes Science and Technology
language:en
Short-container-title:J Diabetes Sci Technol

Author:

Aaron Rachel E.¹^ORCID,Tian Tiffany¹^ORCID,Fleming G. Alexander²^ORCID,Sacks David B.³^ORCID,Januzzi James L.,FACC MD⁴⁵⁶^ORCID,Pop-Busui Rodica⁷^ORCID,Hashim Ibrahim A.⁸^ORCID,Wu Alan H. B.⁹,Pandey Ambarish⁸^ORCID,Klonoff David C.¹⁰^ORCID

Affiliation:

1. Diabetes Technology Society, Burlingame, CA, USA

2. Kinexum, Harpers Ferry, WV, USA

3. National Institutes of Health, Bethesda, MD, USA

4. Cardiology Division, Massachusetts General Hospital, Boston, MA, USA

5. Harvard Medical School, Boston, MA, USA

6. Baim Institute for Clinical Research, Boston, MA, USA

7. University of Michigan, Ann Arbor, MI, USA

8. The University of Texas Southwestern Medical Center, Dallas, TX, USA

9. University of California, San Francisco, San Francisco, CA, USA

10. Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA

Abstract

The Biomarkers for the Diagnosis of Heart Failure in Diabetes webinar was hosted by Diabetes Technology Society on September 20, 2023, with the objective to review current evidence and management practices of biomarker screening for heart failure in people with diabetes. The webinar discussed (1) the four stages of heart failure, (2) diabetes and heart failure, (3) natriuretic peptide and troponin for diagnosing heart failure in diabetes, (4) emerging composite and investigational biomarkers for diagnosing heart failure, and (5) prevention of heart failure progression. Experts in heart failure from the fields of clinical chemistry, cardiology, and diabetology presented data about the importance of screening for heart failure as an often-unnoticed complication of people with type 1 and type 2 diabetes.

Funder

Roche Diagnostics

Publisher

SAGE Publications

Link

https://journals.sagepub.com/doi/pdf/10.1177/19322968241227898

Reference26 articles.

1. Real-World Evidence Supports Higher Prevalence of Heart Failure Among Persons With Type 1 and Type 2 Diabetes Compared With the General Population

2. Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals

3. Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes

4. Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society

5. Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association